Page 176 - SAMRC Annual Report 2024-2025

Studentships cohort in 2025. SAHPRA interns.

In 2024, two new internship programmes were MSc candidates. Some of the conferences where
launched. At the CSIR, two mechanical engineering the candidates presented include the World
graduates were placed as interns to gain hands-on Conference on Lung Health, Human Frontier
experience, and subsequently both were offered Science Programme, Virology Africa, European
employment during their internship. Six interns Rotavirus Biology Meeting and the South African
were also placed at SAHPRA to gain experience Society for Biochemistry and Molecular Biology
in regulatory affairs, quality assurance and clinical Congress. In early 2025, another 11 scholarships
evaluation. (6 PhD and 5 MSc) were awarded.

The programme further includes scholarships In 2024, four candidates were awarded scholarships
for masters and doctoral degrees. A total of 14 to study for an MSc in Pharmacy Administration and
candidates (7 MSc and 7 PhD), selected through Policy Regulation at UWC. This is a two-year course
an open competitive RFA, are being funded from with theoretical modules followed by a dissertation.
the first round to complete their studies, focusing The master’s programme provides regulators
on a variety of vaccine-related topics with the aim and those working in the regulatory departments
of building the next generation of vaccinology of pharmaceutical companies with the skills to
researchers. From this cohort, 8 candidates are lead the development, licensing, and ongoing
anticipated to graduate in 2025 – 2 PhD and 6 pharmacovigilance of drugs in their countries.

A scholarship awardee at the European Rotavirus Biology Meeting.

174 SAMRC ANNUAL REPOR T 2024-25